14719-37-0

Basic information

• Product Name: TERT-BUTOXYCARBONYLAMINO-ACETIC ACID ETHYL ESTER
• Synonyms: N-Boc-glycine Ethyl Ester;Ethyl 2-(tert-butoxycarbonylaMino)acetate;Glycine, N-[(1,1-diMethylethoxy)carbonyl]-, ethyl ester;N-(tert-butoxycarbonyl)glycine ethyl ester;Ethyl [(tert-butoxycarbonyl)amino]acetate;EthylN-(tert-butoxycarbonyl)glycinate;2-(tert-butoxycarbonylamino)acetic acid ethyl ester;2-[(tert-butoxy-oxomethyl)amino]acetic acid ethyl ester
• CAS NO: 14719-37-0
• Molecular Formula: C₉H₁₇NO₄
• Molecular Weight: 203.24
• EINECS: 1533716-785-6
• Mol File: 14719-37-0.mol

Chemical Properties

• Boiling Point: 97°C/0.7mmHg(lit.)
• Flash Point: 125.5oC
• Appearance: Colorless/Oily Liquid
• Density: 1.053g/cm3
• Vapor Pressure: 0.00306mmHg at 25°C
• Refractive Index: 1.4350 to 1.4390
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 11.18±0.46(Predicted)
• CAS DataBase Reference: TERT-BUTOXYCARBONYLAMINO-ACETIC ACID ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: TERT-BUTOXYCARBONYLAMINO-ACETIC ACID ETHYL ESTER(14719-37-0)
• EPA Substance Registry System: TERT-BUTOXYCARBONYLAMINO-ACETIC ACID ETHYL ESTER(14719-37-0)

Safety Data

• Hazardous Substances Data: 14719-37-0(Hazardous Substances Data)

Usage

Uses

Used in Organic Chemistry Research:
TERT-BUTOXYCARBONYLAMINO-ACETIC ACID ETHYL ESTER is used as a protective reagent for [protecting the α-amino group of amino acids] in peptide synthesis for [preventing undesired side reactions].
Used in Biochemistry Research:
TERT-BUTOXYCARBONYLAMINO-ACETIC ACID ETHYL ESTER is used as a protective reagent for [protecting the α-amino group of amino acids] in peptide synthesis for [ensuring efficient and precise synthesis of peptides].
Used in Pharmaceutical Industry:
TERT-BUTOXYCARBONYLAMINO-ACETIC ACID ETHYL ESTER is used as a protective reagent for [protecting the α-amino group of amino acids] in the synthesis of bioactive peptides for [enhancing the stability and bioavailability of the final product].

InChI:InChI=1/C9H17NO4/c1-5-13-7(11)6-10-8(12)14-9(2,3)4/h5-6H2,1-4H3,(H,10,12)

Upstream product

• 66389-79-5 N-tert.-Butoxycarbonyl-N-methoxycarbonylglycinaethylester 
• 50903-47-4 perfluorophenyl 2-((tert-butoxycarbonyl)amino)acetate 
• 16679-94-0 N-[(phenylmethoxy)carbonyl]-L-tyrosine 
• 623-33-6 glycine ethyl ester hydrochloride 
• 219580-32-2 tert-butyl 1H-pyrazole-1-carboxylate 
• 219580-24-2 3,5-Dimethyl-pyrazole-1-carboxylic acid tert-butyl ester 
• 4530-20-5 BOC-glycine 
• 541-41-3 chloroformic acid ethyl ester 
• 24424-99-5 di-tert-butyl dicarbonate 
• 870-46-2 t-butoxycarbonylhydrazine 
• 459-73-4 GlyOEt*HCl 
• 3655-05-8 tert-butoxycarbonylglycine p-nitrophenylester 
• 64-17-5 ethanol 
• 53588-96-8 Malonsaeure-monoetylester-azid 

Downstream Products

• 552335-71-4 Boc-L-2-amino-7-octenoic acid 
• 1219015-26-5 (R)-2-((tert-butoxycarbonyl)amino)oct-7-enoic acid 
• 31925-29-8 (2S,3R)-2-amino-3-hydroxy-3-(4-methylsulfonylphenyl)propionic acid ethyl ester 
• 36983-12-7 D-threo-p-methylsulfonylphenylserine ethyl ester 
• 1449117-74-1 ethyl 1-(tert-butoxycarbonyl)-4-ureido-2,5-dihydro-1H-pyrrole-3-carboxylate 
• 951626-01-0 ethyl 1-(tert-butoxycarbonyl)-4-amino-2,5-dihydro-1H-pyrrole-3-carboxylate 
• 98977-38-9 ethyl (+/-)-1-(tert-butyloxycarbonyl)-3-oxoperhydroazepine-4-carboxylate 
• 1454843-77-6 (±)-5-(tert-butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylic acid 
• 1129634-44-1 (6S)-5-[(tert-butoxy)carbonyl]-5-azaspiro[2.4]heptane-6-carboxylic acid 
• 1011269-18-3 (tert-butoxycarbonyl-phenylethynyl-amino)-acetic acid ethyl ester 
• 1011269-25-2 (tert-butoxycarbonyl-cyclohex-1-enylethynyl-amino)-acetic acid ethyl ester 
• 142229-10-5 trans 1-benzyloxy-3-tert.-butyloxycarbonylamino-4-isopropyl-2-pyrrolidinone 
• 142229-10-5 cis 1-benzyloxy-3-tert.-butyloxycarbonylamino-4-isopropyl-2-pyrrolidinone 

Relevant articles and documents

Design and synthesis novel amide derivatives containing an 1,3,4-oxadiazole moiety as potential antibacterial agents

To find new antibacterial agents, 25 novel amide derivatives containing an 1,3,4-oxadiazole moiety were designed and synthesized, and their antibacterial activity against Xanthomonas oryzae pv. oryzicola (Xoc) and Xanthomonas oryzae pv. oryzae (Xoo) were tested. Interestingly, all target compounds showed excellent antibacterial activities against Xoc and Xoo. The EC50 values of compounds 1–25 against Xoc and Xoo were 1.2–4.0?mg/L and 0.5–2.3?mg/L, respectively, which were significantly superior to those of the thiodiazole copper (95.1 and 89.0?mg/L) and bismerthhibol (73.8 and 68.8?mg/L). For example, the EC50 values of compound 16 against Xoc and Xoo were 1.7 and 0.5?mg/L, respectively. Meanwhile, the curative and protection activity of compound 16 against rice bacterial leaf blight were 42.4% and 42.1%, respectively, which were superior to the control of jiahuangxianjunzuo (34.1% and 32.6%) and thiodiazole copper (33.0% and 27.1%). In addition, compound 16 might suppress the cell growth of Xoo by inhibiting the production of extracellular polysaccharide, the formation of biofilm, changes the cell membrane permeability, and cell surface morphology.

ANTIBIOTICS EFFECTIVE FOR GRAM-NEGATIVE PATHOGENS

Disclosed herein are antibacterial compounds that accumulate in Gram-negative bacteria, methods of preparing the compounds, and methods of using the compounds to inhibit or kill microbes, and methods of treating microbial infections, such as Gram-negative

IONIZABLE CATIONIC LIPID FOR RNA DELIVERY

What is described is a compound of formula I consisting of a compound in which R1 is a branched chain alkyl consisting of 10 to 31 carbons; R2 is a linear alkyl, alkenyl, or alkynyl consisting of 2 to 20 carbons; L1 and L2 are the same or different, each a linear alkylene of 1 to 20 carbons or a linear alkenylene of 2 to 20 carbons; X1 is S or O; R3 is a linear or branched alkylene consisting of 1 to 6 carbons; and R4 and R5 are the same or different, each a hydrogen or a linear or branched alkyl consisting of 1 to 6 carbons; or a pharmaceutically acceptable salt thereof.

IONIZABLE CATIONIC LIPID FOR RNA DELIVERY

What is described is a compound of formula I consisting of a compound in which R1 is a branched chain alkyl consisting of 10 to 31 carbons;R2 is a linear alkyl, alkenyl, or alkynyl consisting of 2 to 20 carbons, or a branched chain alkyl consisting of 10 to 31 carbons;L1 and L2 are the same or different, each a linear alkane of 1 to 20 carbons or a linear alkene of 2 to 20 carbons;X1 is S or O;R3 is a linear or branched alkylene consisting of 1 to 6 carbons; andR4 and R5 are the same or different, each a hydrogen or a linear or branched alkyl consisting of 1 to 6 carbons; or a pharmaceutically acceptable salt thereof.

BICYCLIC AMINES AS NOVEL JAK KINASE INHIBITORS

The present invention relates to a compound according to formula (I) wherein R1 represents alkyl; n is 1 or 2; R2 is selected from the group consisting of hydrogen, cyano, -SO2Ra, -SO2NRbR

New reagent for the introduction of Boc protecting group to amines: Boc-OASUD

A new reagent, tert-butyl (2,4-dioxo-3-azaspiro [5,5] undecan-3-yl) carbonate (Boc-OASUD) for the preparation of N-Boc-amino acids is described. The Boc-OASUD reacts with amino acids and their esters at room temperature in the presence of a base and gives N-Boc-amino acids and their esters in good yields and purity. Introduction of the Boc group takes place without racemization. The Boc-OASUD, being a solid and more stable, is a better alternative to di-tert-butyl dicarbonate which is low melting and has to be dispensed in plastic containers than glass because of its poor stability.

Facile synthesis of hexahydropyrazino[2,3-e]pyrazines from 3-aminomethyl-1,2,4-triazoles

The cyclocondensation of aminomethyl-1,2,4-triazoles and glyoxal gives hexahydropyrazino[2,3-e]pyrazines in good yields. 1H and 13C NMR spectra of the title compounds are described and the molecular structure of 4a,5,6,10a,11,12-hexa

Synthesis of N-propynyl analogues of peptide nucleic acid (PNA) monomers and their use in the click reaction to prepare N-functionalized PNAs

Application of the click reaction for coupling a 2-(2-aminoethoxy)ethoxy (AEE) function to thyminyl, cytosinyl and adeninyl peptide nucleic acid (PNA) monomer analogues bearing a N-propynyl group, in place of the original N-2-aminoethyl moiety, has been explored. The N-propynyl PNA analogues were prepared from glycine ethyl ester hydrochloride and the structure of the thyminyl derivative was confirmed by X-ray diffraction. These monomers were employed in click reactions with Boc-protected AEE azide to afford the corresponding triazolyl-linked PNA-AEE conjugates in yields ranging from 64 to 76%. [1,4]-Regiochemistry was verified from a NOESY correlation experiment.

Combinatorial synthesis of 3,5-Dimethylene substituted 1,2,4-Triazoles

Combinatorial cyclizations of imidates and hydrazides with methylene linked R groups, generated from the corresponding nitriles and carboxylic acids, respectively, provided a large library of 3,5-dimethylene substituted 1,2,4- trizoles. 2011 Bentham Science Publishers Ltd.

Efficient and selective cleavage of the t-butoxycarbonyl group from di-t-butylimidodicarbonate using catalytic bismuth(III) bromide in acetonitrile

Di-t-butylimidodicarbonates can be chemoselectively and efficiently deprotected to the corresponding mono-BOC-protected amines in high yields using a catalytic amount of bismuth(III) bromide in acetonitrile at room temperature. This method is mild and compatible with the presence of a wide range of functional and other protecting groups in the substrates, such as TBDMS, MOM and mono-BOC or Cbz-protected amines, etc. The method has advantages of ease of operation and use of nontoxic and inexpensive catalyst.